LPIN2
protein-codinglipin 2, the group of Lipins
Gene summary
Mouse studies suggest that this gene functions during normal adipose tissue development and may play a role in human triglyceride metabolism. This gene represents a candidate gene for human lipodystrophy, characterized by loss of body fat, fatty liver, hypertriglyceridemia, and insulin resistance. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~127.8 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0012316
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0012316
Submitter: ClinGen
LPIN2 was first reported in relation to autosomal recessive Majeed syndrome in 2005 (Ferguson PJ et al., PMID: 15994876). The syndrome of pediatric-onset congenital dyserythropoietic anemia and chronic recurrent multifocal osteomyelitis was first described in 1989, along with its association with Sweet’s syndrome (Majeed HA et al., PMID: 2809904). Over the years, case reports have expanded the phenotype to include recurrent fevers, elevated acute phase reactants and hepatosplenomegaly. Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found no difference in molecular mechanism, inheritance pattern, nor phenotypic variability. Therefore, the following disease entities have been lumped into one disease, Majeed syndrome (OMIM:609682). Ten variants (missense, nonsense, and splice site) that have been reported in 7 probands in 5 publications (PMIDs: 33993107, 15994876, 37865862, 27252506, 17330256) are included in this curation. Functional data exists that confirms, p.Ser734Leu, leads to impaired protein function via loss of phosphatidic acid phosphatase activity (PMID:197717560). All probands are homozygous and none are known to be de novo. ClinVar reports at total of 37 P/LP variants which include frameshift, large deletion, and compound heterozygous variants (Bhuyan et al., PMID 33314777) but the maximum score for genetic evidence (12 pts.) has been reached. The mechanism of pathogenicity appears to be loss of inhibition. This gene-disease relationship is also supported by in vitro functional assays and cell culture models (PMIDs: 28031477,33314777). Lipin-2 inhibits activation and sensitization of P2X7R, thereby regulating NLRP3 inflammasome assembly. Deficient macrophages have low intracellular cholesterol levels which alter ion currents through the P2X7R. These currents are corrected when cholesterol levels are restored in concordance with decreased inflammasome activation. Patient cells and LPIN2 deficient macrophages demonstrate increased IL-1B expression, caspase 1 activation, and osteoclastogenesis. Pit assays with patient cells demonstrate increased bone resorption. In summary, there is definitive evidence supporting the relationship between LPIN2 and autosomal recessive Majeed Syndrome. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Monogenic Autoinflammatory Disease GCEP on the meeting date May 15, 2024. (SOP Version [10])].
Inheritance Pattern: AR
Disease ID:MONDO:0012316
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0012316
Submitter: Orphanet
Clinical Genomic Database (CGD)
Manifestation: Allergy/Immunology/Infectious; Dermatologic; Hematologic
Intervention: Allergy/Immunology/Infectious; Hematologic
Rationale: Individuals may manifest with Chronic recurrent multifocal osteomyelitis (CRMO), for which treatment with NSAIDs/corticosteroids may be beneficial; Individuals may require surveillance and blood transfusion treatment for anemia
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to LPIN2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001375808.2. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 11 | 209 | 220 | |||
| missense | 2 | 335 | 22 | 1 | 360 | |
| nonsense | 7 | 3 | 4 | 14 | ||
| start loss | 0 | |||||
| frameshift | 15 | 6 | 1 | 22 | ||
| splice donor/acceptor (+/-2bp) | 1 | 15 | 3 | 1 | 20 | |
| Total | 23 | 26 | 354 | 232 | 1 | 636 |
Highest pathogenic variant AF is 0.000022582075
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001362737.1 | 19 | MANE Select | |
| Ensembl | ENSP00000504857.1 | 19 | MANE Select | |
| RefSeq | NP_001362738.1 | 19 | Standard | |
| RefSeq | NP_055461.1 | 19 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Glycerolipid metabolism - Homo sapiens (human)
- Glycerophospholipid metabolism - Homo sapiens (human)
- Adipogenesis
- Metabolism of lipids
- Metabolism
Biological Process
- lipid metabolic process
- phosphatidylethanolamine biosynthetic process
- phosphatidylcholine biosynthetic process
- fatty acid catabolic process
- dephosphorylation
Molecular Function
- transcription coactivator activity
- phosphatidate phosphatase activity
Cellular Component
- nucleus
- endoplasmic reticulum membrane
- cytosol
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000261596
- Coding exons
- 19
- Length
- 96322
- Individuals with no LoFs
- 125686
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 62
- Defined
- 125748
- p
- 0.000247
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.983 | 431 | 492 | 0.875 | 0.0000283 | 5883 |
| Missense (PolyPhen) | 139 | 223.79 | 0.62113 | 2696 | ||
| Synonymous | -1.14 | 215 | 195 | 1.10 | 0.0000133 | 1700 |
| Loss of Function | 4.33 | 17 | 50.0 | 0.340 | 0.00000287 | 579 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00031 | 0.00031 | rare |
| Latino/Admixed American | 0.00017 | 0.00017 | rare |
| Ashkenazi Jewish | 0.0014 | 0.0014 | notable |
| East Asian | 0.00016 | 0.00016 | rare |
| Finnish | 0.000047 | 0.000046 | rare |
| European (Non-Finnish) | 0.00023 | 0.00023 | rare |
| South Asian | 0.00013 | 0.00013 | rare |
| Other | 0.00049 | 0.00049 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Plays important roles in controlling the metabolism of fatty acids at different levels. Acts as a magnesium-dependent phosphatidate phosphatase enzyme which catalyzes the conversion of phosphatidic acid to diacylglycerol during triglyceride, phosphatidylcholine and phosphatidylethanolamine biosynthesis in the reticulum endoplasmic membrane. Acts also as a nuclear transcriptional coactivator for PPARGC1A to modulate lipid metabolism (By similarity). {ECO:0000250}.;
- Disease
- DISEASE: Majeed syndrome (MJDS) [MIM:609628]: An autosomal recessive syndrome characterized by chronic recurrent multifocal osteomyelitis that is of early onset with a lifelong course, congenital dyserythropoietic anemia that presents as hypochromic, microcytic anemia during the first year of life and ranges from mild to transfusion-dependent, and transient inflammatory dermatosis, often manifesting as Sweet syndrome (neutrophilic skin infiltration). {ECO:0000269|PubMed:15994876}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.155
Intolerance Scores
- LoFtool
- 0.319
- RVIS EVS
- -0.79
- RVIS percentile EVS
- 12.57
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.261
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |